1. Introduction: The Evolution of Acid Suppression Therapy For decades, Proton Pump Inhibitors (PPIs) have represented the standard of care for acid-related gastrointestinal disorders. However, real-world clinical data highlights persistent therapeutic gaps: Persistent Symptoms: In survey data of patients on daily PPI regimens, approximately 54% reported persistent reflux symptoms. High Recurrence: Up to 80% of...
1. What is No Cholest? No Cholest is a targeted prescription lipid-lowering agent formulated with Ezetimibe (or as a synergistic combination therapy with statins/nutraceutical lipid complexes). Unlike traditional medications that focus solely on liver cholesterol synthesis, No Cholest acts selectively at the brush border of the small intestine to block dietary and biliary cholesterol absorption,...
1. What is Zasek? Zasek is an advanced prescription gastrointestinal therapy containing Esomeprazole, the purified (S)-enantiomer of omeprazole. As a second-generation Proton Pump Inhibitor (PPI), Zasek delivers powerful, long-lasting reduction of gastric acid production. It is engineered to heal mucosal damage, relieve painful heartburn symptoms, and protect the upper gastrointestinal tract from acid-mediated injury. 2....
1. What is Zaksan? Zaksan is an advanced prescription anticoagulant containing the active substance Apixaban. Available in 2.5 mg and 5 mg film-coated tablets (30-tablet packs), Zaksan belongs to the modern class of Direct Oral Anticoagulants (DOACs). It is clinically formulated to inhibit harmful blood clot formation in veins and arteries while supporting steady, unobstructed...
Committed to advancing global healthcare through the development, manufacturing, and distribution of high-quality pharmaceutical formulations.
© 2026 Zein Pharma. All rights reserved.
